Mineralys Therapeutics, Inc.

MLYS ·Healthcare, Drug Manufacturers - General, United States

SEC Filings

Form	Filed	Description
DEFA14A	Apr 8, 2026	DEFA14A
DEF 14A	Apr 8, 2026	DEF 14A
4	Apr 2, 2026	FORM 4
4	Apr 2, 2026	FORM 4
144	Mar 31, 2026
144	Mar 31, 2026
4	Mar 31, 2026
144	Mar 17, 2026
4	Mar 17, 2026	FORM 4
4	Mar 16, 2026	FORM 4
144	Mar 13, 2026
10-K	Mar 12, 2026	10-K
144	Mar 12, 2026
8-K	Mar 12, 2026	8-K
4	Mar 10, 2026	FORM 4
144	Mar 9, 2026
8-K	Mar 9, 2026	8-K
3	Mar 4, 2026	FORM 3
4	Feb 20, 2026
4	Feb 20, 2026	FORM 4
4	Feb 20, 2026	FORM 4
4	Feb 20, 2026	FORM 4
4	Feb 20, 2026	FORM 4
4	Feb 20, 2026	FORM 4
4	Feb 20, 2026	FORM 4

← Newer Page 4 of 17 · 406 filings Older →